CCOC(=O)CCC(C(=O)OCC)n1nnc2ccc(Nc3c(C)[n+]([O-])c4cc(F)c(OCC)cc4[n+]3[O-])cc21
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?